Senate Confirms Dr. Erica Schwartz as CDC Director, Ending Yearlong Leadership Vacuum

The U.S. Senate on Wednesday confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention in a 51-44 vote, placing her in charge of a public health agency beleaguered by political meddling, mass staff departures, and low morale. Schwartz, 54, becomes the 22nd leader of the Atlanta-based CDC and the agency’s first confirmed director in nearly a year, according to AP News.

The vote was almost entirely along party lines, with only one Senate Democrat, Tim Kaine of Virginia, voting in favor. Schwartz is the first Black woman to lead the CDC, and her confirmation comes at a critical moment as the agency grapples with multiple active outbreaks, including a 15-state cyclosporiasis outbreak, widespread measles transmission, and an Ebola outbreak in the Democratic Republic of the Congo.

A Qualified but Controversial Pick

Schwartz brings an extensive resume to the role, holding medical (MD), public health (MPH), and law (JD) degrees. She spent 24 years in the U.S. Public Health Service Commissioned Corps, served as Deputy Surgeon General during the first Trump administration from January 2019 to April 2021, and was Chief Medical Officer for the U.S. Coast Guard from 2015 to 2019. Most recently, she served as President of Insurance Solutions for Medicare and Retirement at United Healthcare from 2022 until June 2026, as STAT News reported.

Her nomination, announced by President Trump in April 2026, initially drew cautious optimism from public health experts who noted her strong credentials and her background as a public advocate for vaccines and outbreak preparedness. Experts also noted that Schwartz was the choice of Trump rather than Health and Human Services Secretary Robert F. Kennedy Jr., who has been a leading voice in the anti-vaccine movement.

However, Schwartz’s confirmation hearing before the Senate Health, Education, Labor and Pensions Committee on July 15 raised significant concerns. Senators questioned whether she would stand up to Kennedy if he ordered the CDC to take actions unsupported by science. When Sen. Bernie Sanders asked what she would do if put in the same position as her predecessor, Susan Monarez—who was fired after refusing to pre-approve vaccine policy changes—Schwartz responded, “I do not believe that the president or the secretary would ever do what you just mentioned,” prompting Sanders to reply, “Really?”

A Troubled Agency

The CDC has been in turmoil since Trump returned to office in January 2025. The agency has lost more than 3,000 employees—more than one-quarter of its workforce—due to layoffs and resignations, as documented by KFF Health News. The first wave of mass firings in February 2025 was dubbed the “Valentine’s Day massacre” by staffers. Morale has plummeted as a succession of mostly temporary leaders has come and gone, and the front office has been staffed by political appointees with little or no training in medicine or public health.

Schwartz is the third Trump nominee for CDC director in the past 18 months. The first, former Florida congressman Dr. David Weldon, had his Senate hearing canceled in March 2025 an hour before it was to begin. The second, Susan Monarez, was confirmed by the Senate but ousted in less than a month after refusing to fire CDC experts and pre-approve changes to vaccine policy recommended by Kennedy. NIH Director Jay Bhattacharya has been serving as acting CDC director since February 2026.

The agency’s challenges extend beyond staffing. CDC employees are still reeling from a shooting at agency headquarters in Atlanta in August 2025, when a gunman with anti-vaccine motives killed DeKalb County police officer David Rose before taking his own life. Multiple employees have reported that the federal government has yet to fully fix the damage to windows and buildings hit in the shooting.

Confirmation Battle and Key Support

Schwartz’s confirmation was far from assured. After her July hearing, the National Public Health Coalition, an organization of former and current CDC workers, issued a statement opposing her nomination. “The public and Congress deserve a CDC Director who will follow the law, defend science, protect public health workers, and rebuild the systems that keep communities safe,” the group said. “Based on what we saw during the Senate HELP Committee hearing on July 15, 2026, NPHC cannot support Dr. Schwartz’s nomination.”

Critical to her confirmation was support from Senate HELP Committee Chairman Bill Cassidy (R-La.), a self-proclaimed vaccine advocate who initially expressed disappointment with her hearing performance. After speaking with Schwartz again and consulting with those who served with her, Cassidy signaled his support on July 23. “I’m confident that she knows what she is doing and will stand against those who do not,” he said, as reported by CIDRAP.

During her confirmation hearing, Schwartz made firm pledges about her approach. “As CDC director, my sacred responsibility is to provide the American people with public health guidance that is clear, honest and evidence based,” she said. “I will never betray the science.” She also stated that she supported the withdrawal of the United States from the World Health Organization.

What Experts Are Saying

Public health leaders have expressed cautious hope mixed with deep concern about what lies ahead. Dr. Georges Benjamin, CEO of the American Public Health Association, said the CDC “desperately needs stability, experienced leadership and a steadfast commitment to science” after the turmoil of the past two years, according to NPR.

But Benjamin also acknowledged the difficult balancing act Schwartz faces. “Public health people in these positions often have to manage through influence. You don’t get influence by disagreeing with your boss publicly before you even get the job,” he said.

Others are more skeptical. Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, called Schwartz’s hearing performance “an evasion” and said “her performance came up far short of what I was hoping for.” He questioned whether anyone with professional integrity could survive in the current environment, telling NPR that he doesn’t “know how someone that has integrity or professional commitment to the field can actually survive in this situation and not have the same fate.”

Dr. Mandy Cohen, who served as CDC director under President Biden, acknowledged the scale of the challenge. “The new director is stepping into a moment where the agency has been under a lot of strain,” she said. “Her job is to navigate between the policy world and the scientific world, and make sure they stay in alignment with each other. That is going to be a hard job for her.”

Dr. Dan Jernigan, a former top CDC official who resigned last year, offered a blunt assessment: “My personal view is that anybody that takes the position as director of CDC at this time should come through the door on day one ready to get fired.”

The Road Ahead

Schwartz is expected to be sworn in within the coming days. She will inherit an agency facing immediate public health crises—including the cyclosporiasis outbreak that has sickened more than 18,000 people across 45 states, a measles outbreak that has reached a 35-year high of 2,318 cases, and an Ebola outbreak in the Democratic Republic of the Congo—alongside the longer-term challenges of rebuilding workforce morale and restoring the agency’s credibility.

The National Public Health Coalition struck a measured tone in its post-confirmation statement. “Now, Dr. Schwartz needs to prove that her leadership will serve science and not the whims of politicians,” the group said. “CDC needs a Director who will protect public health workers, defend evidence-based guidance, and refuse any directive that would undermine public safety.”

Whether Schwartz can navigate between the scientific mission of the CDC and the political pressures of the administration that appointed her remains the central question of her tenure. As Ars Technica noted, her confirmation “ends a nearly yearlong vacancy for the position since Kennedy fired the previous CDC director.” The agency and the public health community will be watching closely to see whether she can restore stability to an institution that has been in crisis for nearly two years.